Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Depreciation & Amortization (CF) (2020 - 2025)

BioAtla (BCAB) has 6 years of Depreciation & Amortization (CF) data on record, last reported at $56000.0 in Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) fell 75.44% year-over-year to $56000.0; the TTM value through Sep 2025 reached $582000.0, down 45.35%, while the annual FY2024 figure was $925000.0, 24.24% down from the prior year.
  • Depreciation & Amortization (CF) reached $56000.0 in Q3 2025 per BCAB's latest filing, down from $115000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $380000.0 in Q3 2021 and bottomed at $56000.0 in Q3 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $264684.2, with a median of $290000.0 recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): skyrocketed 52.09% in 2021, then tumbled 75.44% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $314000.0 in 2021, then decreased by 5.1% to $298000.0 in 2022, then increased by 23.49% to $368000.0 in 2023, then plummeted by 38.04% to $228000.0 in 2024, then crashed by 75.44% to $56000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $56000.0 in Q3 2025, $115000.0 in Q2 2025, and $183000.0 in Q1 2025.